Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-08-15 18:47:39 UTC |
---|
Updated at | 2024-09-27 20:17:54 UTC |
---|
NP-MRD ID | NP0333731 |
---|
Natural Product DOI | https://doi.org/10.57994/3210 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Alligamycin B |
---|
Description | It was first documented in 2024 (PMID: 39313764). Based on a literature review a significant number of articles have been published on Alligamycin B (PMID: 39313749) (PMID: 39313744) (PMID: 39313710) (PMID: 39313706). |
---|
Structure | CO[C@H](C[C@H]1OC(=O)[C@H](CCCCCCC(C)=O)[C@@H](O)\C(C)=C\C(=O)C[C@H](C)CC[C@H]2CC[C@@H](C)[C@@]3(C[C@H](O)C[C@@H](CC(=O)[C@H]1C)O3)O2)[C@@H](C)[C@H](O)C(=C\C=C\C(O)=O)\C(=O)OC InChI=1S/C48H74O15/c1-28-18-20-36-21-19-30(3)48(62-36)27-35(51)24-37(63-48)25-40(52)32(5)42(26-41(59-7)33(6)45(56)39(46(57)60-8)16-13-17-43(53)54)61-47(58)38(15-12-10-9-11-14-31(4)49)44(55)29(2)23-34(50)22-28/h13,16-17,23,28,30,32-33,35-38,41-42,44-45,51,55-56H,9-12,14-15,18-22,24-27H2,1-8H3,(H,53,54)/b17-13+,29-23+,39-16-/t28-,30-,32-,33-,35-,36+,37+,38-,41-,42-,44+,45+,48+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C48H74O15 |
---|
Average Mass | 891.1050 Da |
---|
Monoisotopic Mass | 890.50277 Da |
---|
IUPAC Name | (2E,4Z,6S,7S,8R)-9-[(1S,3R,5S,8S,9R,12R,13R,14E,18R,21S,24R)-3,13-dihydroxy-8,14,18,24-tetramethyl-7,11,16-trioxo-12-(7-oxooctyl)-10,25,26-trioxatricyclo[19.3.1.1^{1,5}]hexacos-14-en-9-yl]-6-hydroxy-8-methoxy-5-(methoxycarbonyl)-7-methylnona-2,4-dienoic acid |
---|
Traditional Name | (2E,4Z,6S,7S,8R)-9-[(1S,3R,5S,8S,9R,12R,13R,14E,18R,21S,24R)-3,13-dihydroxy-8,14,18,24-tetramethyl-7,11,16-trioxo-12-(7-oxooctyl)-10,25,26-trioxatricyclo[19.3.1.1^{1,5}]hexacos-14-en-9-yl]-6-hydroxy-8-methoxy-5-(methoxycarbonyl)-7-methylnona-2,4-dienoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CO[C@H](C[C@H]1OC(=O)[C@H](CCCCCCC(C)=O)[C@@H](O)\C(C)=C\C(=O)C[C@H](C)CC[C@H]2CC[C@@H](C)[C@@]3(C[C@H](O)C[C@@H](CC(=O)[C@H]1C)O3)O2)[C@@H](C)[C@H](O)C(=C\C=C\C(O)=O)\C(=O)OC |
---|
InChI Identifier | InChI=1S/C48H74O15/c1-28-18-20-36-21-19-30(3)48(62-36)27-35(51)24-37(63-48)25-40(52)32(5)42(26-41(59-7)33(6)45(56)39(46(57)60-8)16-13-17-43(53)54)61-47(58)38(15-12-10-9-11-14-31(4)49)44(55)29(2)23-34(50)22-28/h13,16-17,23,28,30,32-33,35-38,41-42,44-45,51,55-56H,9-12,14-15,18-22,24-27H2,1-8H3,(H,53,54)/b17-13+,29-23+,39-16-/t28-,30-,32-,33-,35-,36+,37+,38-,41-,42-,44+,45+,48+/m1/s1 |
---|
InChI Key | BDMBBPLBQQUAEP-HYVOKNBOSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
NOESY NMR | [1H, 1H] NMR Spectrum (2D, 800 MHz, CDCl3, experimental) | yiqiao@dtu.dk | Technical University of Denmark | Yijun Qiao | 2024-08-15 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental) | yiqiao@dtu.dk | Technical University of Denmark | Yijun Qiao | 2024-08-15 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 800 MHz, CDCl3, experimental) | yiqiao@dtu.dk | Technical University of Denmark | Yijun Qiao | 2024-08-15 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental) | yiqiao@dtu.dk | Technical University of Denmark | Yijun Qiao | 2024-08-15 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CDCl3, experimental) | yiqiao@dtu.dk | Technical University of Denmark | Yijun Qiao | 2024-08-15 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
iranensis | | |
|
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kara D, Liu Y, Chen S, Garrett T, Younis A, Sugawara M, Bolen MA, Bi X, Wazni O, Nakagawa H, Kwon D, Nguyen C: In vivo cardiac diffusion tensor imaging on an MR system featuring ultrahigh performance gradients with 200 mT/m maximum gradient strength. Magn Reson Med. 2024 Sep 23. doi: 10.1002/mrm.30308. [PubMed:39313764 ]
- Peng D, Yang S, Zhai H: The causal relationship between cholecystectomy and IBD/IBS and the role of bile acids and gut microbiota: a two-sample Mendelian randomization study. Int J Colorectal Dis. 2024 Sep 24;39(1):149. doi: 10.1007/s00384-024-04726-4. [PubMed:39313749 ]
- Sahli E, Ozmert E, Gunel MD, Atilla H: Evaluation of the efficacy of subtenon autologous platelet-rich plasma therapy in patients with retinitis pigmentosa and factors affecting response to the treatment. Int Ophthalmol. 2024 Sep 23;44(1):388. doi: 10.1007/s10792-024-03305-4. [PubMed:39313744 ]
- Kancherla R, Lohith TN, Deshmukh S, Mulka SR, Kuruvalli G, Reddy MBM: Synthesis, spectroscopic characterization, DFT calculations, in silico-ADMET and molecular docking analysis of novel quinoline-substituted 5H-chromeno [2,3-b] pyridine derivatives as antibacterial agents. Mol Divers. 2024 Sep 23. doi: 10.1007/s11030-024-10982-x. [PubMed:39313710 ]
- Wei L, Zhang L, Zhao D, Ma Y, Yang L: The characteristic activity of regulatory B cells during the occurrence and development of insulin resistance. Endocrine. 2024 Sep 23. doi: 10.1007/s12020-024-04040-7. [PubMed:39313706 ]
|
---|